Background:
Vitamin D has an immunoregulatory action in Inflammatory Bowel Disease (IBD) as well
as other immune-mediated disorders. Its influence on intestinal permeability, innate and adaptive immunity, and the
composition and diversity of the microbiota contribute to the maintenance of intestinal homeostasis. Patients with
IBD have a greater prevalence of vitamin D deficiency than the general population, and a possible association between
this deficit and a worse course of the disease. However, intervention studies in patients with IBD have proved
inconclusive.
Objective:
To review all the evidence concerning the role of vitamin D as an important factor in the pathophysiology
of IBD, review the associations found between its deficiency and the prognosis of the disease, and draw conclusions
for the practical application from the main intervention studies undertaken.
Method:
Structured search and review of basic, epidemiological, clinical and intervention studies evaluating the
influence of vitamin D in IBD, following the basic principles of scientific data.
Results:
Vitamin D deficiency is associated with disease activity, quality of life, the consumption of social and
healthcare resources, and the durability of anti-TNFα biological treatment. Determination of new metabolites of
vitamin D, measurement of its absorption capacity and questionnaires about sun exposure could help identify groups
of IBD patients with a special risk of vitamin D deficiency.
Conclusion:
Well-designed intervention studies are needed in IBD, with probably higher objective plasma doses of
vitamin D to establish its efficacy as a therapeutic agent with immunomodulatory properties. Meanwhile, vitamin D
deficiency should be screened for and corrected in affected patients in order to achieve adequate bone and phosphocalcic
metabolism.
This paper reviews some of the key aspects of these new drugs, including their mechanism of action, some incipient pharmacokinetic and metabolic data, their efficacy and their safety. These new agents will take on an important role in the coming years in the management of patients with moderate-to-severe forms of inflammatory bowel disease.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.